A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease.
Clinical trial NCT05924243 · COMPLETED
Trial details
- NCT number
- NCT05924243
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-22
- Primary completion
- 2024-07-18
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.